Effectiveness of Population-Based Service Screening With Mammography for Women Ages 40 to 49 Years Evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort

被引:184
作者
Hellquist, Barbro Numan [1 ]
Duffy, Stephen W. [2 ]
Abdsaleh, Shahin [3 ]
Bjorneld, Lena [4 ]
Bordas, Pal [5 ]
Tabar, Laszlo [6 ]
Vitak, Bedrich [7 ]
Zackrisson, Sophia [8 ]
Nystrom, Lennarth [9 ]
Jonsson, Hakan [1 ]
机构
[1] Umea Univ, Dept Radiat Sci, S-90185 Umea, Sweden
[2] Queen Mary Univ London, Bails & London Sch Med & Dent, Wolfson Inst Prevent Med, Canc Res UK,Dept Epidemiol Math & Stat, London, England
[3] Univ Uppsala Hosp, Dept Med Imaging, Uppsala, Sweden
[4] Sahlgrens Univ Hosp, Dept Radiol, Sahlgrenska, Sweden
[5] Sunderby Hosp, Dept Radiol, Norrbotten Mammog Screening Program, Sunderby, Sweden
[6] Falun Cent Hosp, Dept Mammog, Falun, Sweden
[7] Linkoping Univ Hosp, Mammog Dept, S-58185 Linkoping, Sweden
[8] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden
[9] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden
关键词
mammography; screening; breast cancer; mortality; BREAST-CANCER MORTALITY; FOLLOW-UP; TRIAL; SWEDEN;
D O I
10.1002/cncr.25650
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The effectiveness of mammography screening for women ages 40 to 49 years still is questioned, and few studies of the effectiveness of service screening for this age group have been conducted. METHODS: Breast cancer mortality was compared between women who were invited to service screening at ages 40 to 49 years (study group) and women in the same age group who were not invited during 1986 to 2005 (control group). Together, these women comprise the Mammography Screening of Young Women (SCRY) cohort, which includes all Swedish counties. A prescreening period was defined to facilitate a comparison of mortality in the absence of screening. The outcome measure was refined mortality, ie, breast cancer death for women who were diagnosed during follow-up at ages 40 to 49 years. Relative risks (RRs) with 95% confidence intervals (Os) were estimated. RESULTS: There was no significant difference in breast cancer mortality during the prescreening period. During the study period, there were 803 breast cancer deaths in the study group (7.3 million person-years) and 1238 breast cancer deaths in the control group (8.8 million person-years). The average follow-up was 16 years. The estimated RR for women who were invited to screening was 0.74 (95% Cl, 0.66-0.83), and the RR for women who attended screening was 0.71 (95% CI, 0.620.80). CONCLUSIONS: In this comprehensive study, mammography screening for women ages 40 to 49 years was efficient for reducing breast cancer mortality. Cancer 2011;117:714-22. (C) 2010 American Cancer Society.
引用
收藏
页码:714 / 722
页数:9
相关论文
共 21 条
[1]   MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL [J].
ANDERSSON, I ;
ASPERGREN, K ;
JANZON, L ;
LANDBERG, T ;
LINDHOLM, K ;
LINELL, F ;
LJUNGBERG, O ;
RANSTAM, J ;
SIGFUSSON, B .
BRITISH MEDICAL JOURNAL, 1988, 297 (6654) :943-948
[2]  
Andersson I, 1997, J Natl Cancer Inst Monogr, P63
[3]  
Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO
[4]  
2-#
[5]   Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement [J].
Calonge, Ned ;
Petitti, Diana B. ;
DeWitt, Thomas G. ;
Dietrich, Allen J. ;
Gregory, Kimberly D. ;
Grossman, David ;
Isham, George ;
LeFevre, Michael L. ;
Leipzig, Rosanne M. ;
Marion, Lucy N. ;
Melnyk, Bernadette ;
Moyer, Virginia A. ;
Ockene, Judith K. ;
Sawaya, George F. ;
Schwartz, J. Sanford ;
Wilt, Timothy .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (10) :716-W236
[6]  
Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO
[7]  
2-V
[8]  
Duffy S W, 1997, J Natl Cancer Inst Monogr, P93
[9]   RANDOMIZED STUDY OF MAMMOGRAPHY SCREENING - PRELIMINARY-REPORT ON MORTALITY IN THE STOCKHOLM TRIAL [J].
FRISELL, J ;
EKLUND, G ;
HELLSTROM, L ;
LIDBRINK, E ;
RUTQVIST, LE ;
SOMELL, A .
BREAST CANCER RESEARCH AND TREATMENT, 1991, 18 (01) :49-56
[10]  
Jonsson H, 2000, ACTA ONCOL, V39, P617